The hazard ratio for cancer associated with heart failure was 2.16 and was 1.71, after adjustments.
Your search for comorbidities returned 19 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
The American College of Cardiology released a decision pathway addressing 10 pivotal issues in heart failure with reduced ejection fraction.
Patients with heart failure with reduced ejection fraction who received any guideline-directed medical therapy were less likely to die within 1 year of implantable cardioverter-defibrillator placement.
Out 952 patients, 20 experienced sudden cardiac death/malignant ventricular arrhythmias within the first 6 months of the study enrollment.
Structural heart disease variables associated with death included left ventricular ejection fraction ≤45% and right ventricular systolic dysfunction.
Long-chain acylcarnitine metabolites (factors 5 and 7) were associated with an increased risk of all-cause mortality or hospitalization.
Researchers analyzed the relationship between chronotropic incompetence and exercise capacity in patients with chronic heart failure.
Previously abandoned leads were associated with more complications from infection.